IRIS Accounts Production v24.3.2.46 09064960 director 1.7.23 30.6.24 30.6.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090649602023-06-30090649602024-06-30090649602023-07-012024-06-30090649602022-06-30090649602022-07-012023-06-30090649602023-06-3009064960ns15:EnglandWales2023-07-012024-06-3009064960ns14:PoundSterling2023-07-012024-06-3009064960ns10:Director12023-07-012024-06-3009064960ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3009064960ns10:SmallEntities2023-07-012024-06-3009064960ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3009064960ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3009064960ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3009064960ns10:FullAccounts2023-07-012024-06-3009064960ns10:CompanySecretary12023-07-012024-06-3009064960ns10:RegisteredOffice2023-07-012024-06-3009064960ns5:CurrentFinancialInstruments2024-06-3009064960ns5:CurrentFinancialInstruments2023-06-3009064960ns5:ShareCapital2024-06-3009064960ns5:ShareCapital2023-06-3009064960ns5:RetainedEarningsAccumulatedLosses2024-06-3009064960ns5:RetainedEarningsAccumulatedLosses2023-06-3009064960ns5:ComputerEquipment2023-07-012024-06-3009064960ns5:FurnitureFittings2023-06-3009064960ns5:ComputerEquipment2023-06-3009064960ns5:FurnitureFittings2023-07-012024-06-3009064960ns5:FurnitureFittings2024-06-3009064960ns5:ComputerEquipment2024-06-3009064960ns5:FurnitureFittings2023-06-3009064960ns5:ComputerEquipment2023-06-3009064960ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3009064960ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-30
REGISTERED NUMBER: 09064960 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

FOR

G&SS MEDICAL LTD

G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 June 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


G&SS MEDICAL LTD

COMPANY INFORMATION
for the Year Ended 30 June 2024







DIRECTOR: Dr G Subramanian





SECRETARY: S H Subramanian





REGISTERED OFFICE: Ivy Cottage
School Lane
Halam
Newark
Nottinghamshire
NG22 8AD





REGISTERED NUMBER: 09064960 (England and Wales)





ACCOUNTANTS: Beeley Hawley & Co. Ltd
Chartered Accountants
42-44 Nottingham Road
Mansfield
Nottinghamshire
NG18 1BL

G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)

BALANCE SHEET
30 June 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,487 2,015

CURRENT ASSETS
Debtors 5 107,118 64,584
Cash at bank 164,321 141,603
271,439 206,187
CREDITORS
Amounts falling due within one year 6 62,812 41,044
NET CURRENT ASSETS 208,627 165,143
TOTAL ASSETS LESS CURRENT
LIABILITIES

211,114

167,158

CAPITAL AND RESERVES
Called up share capital 7 7
Retained earnings 211,107 167,151
SHAREHOLDERS' FUNDS 211,114 167,158

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 17 January 2025 and were signed by:





Dr G Subramanian - Director


G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 June 2024

1. STATUTORY INFORMATION

G&SS Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

G&SS MEDICAL LTD (REGISTERED NUMBER: 09064960)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 June 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 July 2023 1,300 6,556 7,856
Additions 175 1,436 1,611
At 30 June 2024 1,475 7,992 9,467
DEPRECIATION
At 1 July 2023 752 5,089 5,841
Charge for year 181 958 1,139
At 30 June 2024 933 6,047 6,980
NET BOOK VALUE
At 30 June 2024 542 1,945 2,487
At 30 June 2023 548 1,467 2,015

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 106,731 64,167
Other debtors 387 417
107,118 64,584

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 31,709 21,420
Social security and other taxes 305 316
VAT 24,725 14,367
Directors' loan accounts 3,656 2,635
Accrued expenses 2,417 2,306
62,812 41,044